MX2023000479A - Composiciones farmaceuticas orales hinchables. - Google Patents

Composiciones farmaceuticas orales hinchables.

Info

Publication number
MX2023000479A
MX2023000479A MX2023000479A MX2023000479A MX2023000479A MX 2023000479 A MX2023000479 A MX 2023000479A MX 2023000479 A MX2023000479 A MX 2023000479A MX 2023000479 A MX2023000479 A MX 2023000479A MX 2023000479 A MX2023000479 A MX 2023000479A
Authority
MX
Mexico
Prior art keywords
swellable
pharmaceutical compositions
oral pharmaceutical
administration
compositions
Prior art date
Application number
MX2023000479A
Other languages
English (en)
Inventor
Nathan Dormer
Michelle K Schilling
Jeffrey Overfield
Original Assignee
Adare Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adare Pharmaceuticals Inc filed Critical Adare Pharmaceuticals Inc
Publication of MX2023000479A publication Critical patent/MX2023000479A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen composiciones orales hinchables que, tras la adición de agua, forman productos semisólidos antes de la administración. Las composiciones son particularmente adecuadas para la administración a sujetos que pueden tener dificultad o desagrado a tragar composiciones orales sólidas, tales como comprimidos y cápsulas.
MX2023000479A 2020-07-10 2021-07-12 Composiciones farmaceuticas orales hinchables. MX2023000479A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063050363P 2020-07-10 2020-07-10
PCT/US2021/041277 WO2022011341A1 (en) 2020-07-10 2021-07-12 Swellable oral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2023000479A true MX2023000479A (es) 2023-02-13

Family

ID=77227128

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000479A MX2023000479A (es) 2020-07-10 2021-07-12 Composiciones farmaceuticas orales hinchables.

Country Status (8)

Country Link
US (1) US20230248654A1 (es)
EP (1) EP4178549A1 (es)
JP (1) JP2023533420A (es)
KR (1) KR20230038183A (es)
CN (1) CN115768410A (es)
CA (1) CA3178341A1 (es)
MX (1) MX2023000479A (es)
WO (1) WO2022011341A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1242055B1 (en) * 1999-12-23 2008-04-23 Pfizer Products Inc. Hydrogel-driven drug dosage form
EP1355630B1 (en) 2000-08-15 2009-11-25 The Board Of Trustees Of The University Of Illinois Method of forming microparticles
US7309500B2 (en) 2003-12-04 2007-12-18 The Board Of Trustees Of The University Of Illinois Microparticles
EP2258349B1 (en) 2004-05-11 2014-07-16 Egalet Ltd. Swellable dosage form comprising gellan gum
EP2790729A4 (en) 2011-12-12 2015-08-12 Orbis Biosciences Inc PARTICULATE FORMULATIONS WITH DELAYED RELEASE
EP3110403B1 (en) 2014-02-25 2019-11-06 Orbis Biosciences, Inc. Taste masking drug formulations
KR20150144585A (ko) 2014-06-17 2015-12-28 엘지전자 주식회사 태양 전지의 후처리 장치

Also Published As

Publication number Publication date
CN115768410A (zh) 2023-03-07
CA3178341A1 (en) 2022-01-13
US20230248654A1 (en) 2023-08-10
WO2022011341A1 (en) 2022-01-13
EP4178549A1 (en) 2023-05-17
KR20230038183A (ko) 2023-03-17
JP2023533420A (ja) 2023-08-03

Similar Documents

Publication Publication Date Title
CY1119140T1 (el) Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους
MX2017012878A (es) Composiciones gomosas de multicomponentes con nucleo duro.
WO2011053653A3 (en) Prevotella histicola preparations and the treatment of autoimmune conditions
CY1115652T1 (el) Μορφη δοσολογιας που περιεχει δυο δραστικα φαρμακευτικα συστατικα μειγματος σε διαφορετικες φυσικες μορφες
HUP0302876A2 (hu) Gyógyszerészeti kiszerelés
PH12020550341A1 (en) Niraparib formulations
IL179718A0 (en) Pharmaceutical composition containing irbesartan
WO2007075475A3 (en) Gastric reflux resistant dosage forms
MXPA06010146A (es) Formas de dosificacion solidas biodisponibles de metaxalona.
BRPI0513598A (pt) formas de dosagem em comprimidos revestidos de liberação entérica
WO2011116139A3 (en) Improved pharmaceutical compositions comprising cck- 8 and methods of delivery
NZ595127A (en) Stable pharmaceutical composition for atherosclerosis
CY1118057T1 (el) Φαρμακευτικη συνθεση για στοματικη χορηγηση
EA201290985A1 (ru) Пероральные ветеринарные фармацевтические и нутрицевтические композиции
WO2017037075A8 (de) Zusammensetzung enthaltend einen extrakt aus echinacea und linolsäurederivate
PH12015500823A1 (en) Modified release formulations for oprozomib
EP4282414A3 (en) Modified release tablet formulations containing phosphodiesterase inhibitors
PH12020550815A1 (en) Delayed release deferiprone tablets and methods of using the same
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
MA32635B1 (fr) Produit medicamenteux et traitement associe
MX2017005163A (es) Composiciones de liberación prolongada de onapristona y métodos.
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
MX2023000479A (es) Composiciones farmaceuticas orales hinchables.
ITMI20121317A1 (it) Composizioni per il trattamento della fatica oncologica
JP6293553B2 (ja) 含硫化合物の硫黄臭のマスキング方法